InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
End Game Free
06/07/22 9:30 PM
profile icon
End Game Free
08/26/21 10:05 AM
profile icon
End Game Free
08/25/21 9:25 AM
profile icon
buxmaker Free
08/24/21 10:08 PM
profile icon
End Game Free
08/24/21 11:37 AM
profile icon
End Game Free
08/24/21 8:58 AM
profile icon
End Game Free
08/23/21 8:49 PM
profile icon
End Game Free
08/21/21 10:42 PM
profile icon
buxmaker Free
08/21/21 10:24 AM
profile icon
End Game Free
08/17/21 3:35 PM
profile icon
mike25 Free
07/23/21 4:20 PM
profile icon
buxmaker Free
07/23/21 2:44 PM
profile icon
buxmaker Free
07/23/21 2:01 PM
profile icon
mike25 Free
07/19/21 1:21 PM
profile icon
End Game Free
07/12/21 6:41 PM
profile icon
End Game Free
07/12/21 4:19 PM
profile icon
End Game Free
07/11/21 12:30 PM
profile icon
End Game Free
07/08/21 4:25 PM
profile icon
End Game Free
07/08/21 4:16 PM
profile icon
End Game Free
07/07/21 10:50 AM
profile icon
End Game Free
07/01/21 3:58 PM
profile icon
buxmaker Free
07/01/21 3:55 PM
profile icon
End Game Free
07/01/21 3:54 PM
profile icon
buxmaker Free
07/01/21 1:33 PM
profile icon
End Game Free
05/06/21 4:40 PM
profile icon
End Game Free
05/03/21 12:59 AM
profile icon
End Game Free
05/02/21 9:40 PM
profile icon
End Game Free
05/01/21 10:39 AM
profile icon
End Game Free
04/27/21 1:25 PM

Verisante Technology Inc (VRS.H) RSS Feed

Followers
27
Posters
67
Posts (Today)
0
Posts (Total)
1302
Created
02/02/11
Type
Free
Moderators



 

US: VRSEF    Canada: VRS.V

Outstanding Shares 55,608,813

www.verisante.com

About Verisante Technology:

Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer.


The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and the University of British Columbia and tested and refined on approximately 1,000 lesions at the Skin Care Centre at Vancouver General Hospital.

This exclusive platform technology allows Verisante to develop and offer a range of compact, non-invasive cancer detection devices that offer immediate results for many of the most common cancers.


Company Contact Info

Investor Relations

306 - 2309 West 41st Avenue
Vancouver BC V6M 2A3

Contact Information:

Tel: 604-605-0507

Fax: 604-605-0508


Email: info@verisante.com

https://www.facebook.com/verisante

http://twitter.com/#!/Verisante




Press Releases 2012

For a complete list of all PRs, click Here
 

Press Releases 2011

For a complete list of all PRs, click Here

Press Releases 2010

For a complete list of all PRs, click Here

Press Releases 2009

For a complete list of all PRs, click Here





 
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
VRS.H Latest News
  • No Recent News Available for this company!
New Post